Navigation Links
Cedars-Sinai movement disorders expert on international task force for dystonia treatment
Date:7/21/2011

LOS ANGELES (July 20, 2011) Neurologist Michele Tagliati, MD, director of the Movement Disorders Program at Cedars-Sinai Medical Center, served on an elite international task force commissioned by the Movement Disorder Society to provide insights and guidance on deep brain stimulation for dystonia, an uncommon condition that causes sustained, sometimes crippling muscle contractions.

The resulting articles, describing the data reviewed and outlining the group's conclusions, recommendations and points to be addressed in future research, published online last month in a special supplement to the journal Movement Disorders.

With members from Asia, Europe and North and South America, the task force critically reviewed, discussed and debated current practice and research before reaching consensus on issues facing treatment professionals. The group included neurologists, neurosurgeons, neurophysiologists, neuropsychiatrists, neuropsychologists and nurses with expertise and experience in deep brain stimulation for dystonia.

Tagliati made major contributions to two articles reviewing postoperative issues: "Long-Term Management of DBS in Dystonia: Response to Stimulation, Adverse Events, Battery Changes, and Special Considerations," and "Early Postoperative Management: Programming, Medication Changes, and Evaluations." He was the only member from the United States in the group studying post-surgical management of patients undergoing deep brain stimulation.

"We reviewed the research literally paper by paper and line by line to come up with these documents," he said. "We separated credible papers from less authoritative papers and tried to extract what we could define as reliable evidence, separating solid data from that which is not as strong. Deep brain stimulation was developed in Europe and later adopted in the United States and many of the experts are in Europe because they've done it for a longer time. It was an honor for me to be assigned a leadership role in this kind of effort."

Dystonia causes muscles to contract, with the affected body part twisting involuntarily. There are several types of dystonia, with symptoms ranging from mild to severe. The Food and Drug Administration approved deep brain stimulation as a therapy for certain treatment-resistant dystonias in 2003 after approving it for essential tremor in 1997 and Parkinson's disease in 2002. The procedure recently was approved on a limited basis for obsessive-compulsive disorder.

"The fantastic thing is that with a certain type of dystonia young-onset dystonia DBS is not just a good therapy, but it can be a miraculous therapy, and I don't hesitate to use that term," said Tagliati, who has studied deep brain stimulation for more than a decade. "We have videos that are mind-boggling because they show kids in wheelchairs, with very bad distortions, who become normal. Not 80 percent better. Normal. They go and play basketball."

The device consists of electrical leads implanted in the brain and a stimulator located near the collarbone. The stimulator is programmed with a remote, handheld controller to modulate abnormal nerve signals that cause the uncontrollable muscle contractions of dystonia. According to studies cited by the task force, the procedure provides sustained benefit for patients with dystonia for up to three years and evidence grows that positive outcomes may extend up to 10 years.

Tagliati said DBS therapy is not effective in all cases and device implantation and programming are not without risk. The mechanism and batteries themselves can be subject to failure, although newer devices and redundant power sources reduce these risks. "Our studies and the published article point out that adverse events occasionally occur with DBS, and these range from annoying to life-threatening, with speech abnormalities being the most common programming side effects. The article offers recommendations for predicting, reducing and dealing with adverse events."

Tagliati, who leads an educational course on deep brain stimulation programming every year at the American Academy of Neurology meetings, said the Movement Disorders articles define the current state of the art for this therapy for dystonia. The American Academy of Neurology is conducting a similar data review that may establish guidelines for those who treat dystonia with deep brain stimulation.

Tagliati and his counterpart at the University of California, Los Angeles Jeff M. Bronstein, MD, PhD recently led another panel of international experts in developing a consensus on key issues related to deep brain stimulation for Parkinson's disease. Their work, with insight and guidance for practitioners, was published in Archives of Neurology last October.

Dystonia is less common than Parkinson's disease and has been more of a medical mystery, even among many movement disorders specialists. The principles of deep brain stimulation are similar for each disorder, but the devices are placed in slightly different locations. Proper placement and precise, individualized programming are critical to success, and Tagliati said many cases of seemingly "failed" therapy can be corrected through expert fine-tuning of the device, along with proper medication management.

"Doctors are taught how to measure electricity coming from the muscles or from the brain, but they know little about 'injecting' electricity as a therapy. With DBS, there was a clinical science that needed to be developed," said Tagliati, who became interested in the procedure while completing a fellowship in movement disorders with top experts in the field. He has devoted his career to advancing the science of programming of the stimulator.

"We're establishing at Cedars-Sinai a center of excellence where deep brain stimulation is viewed as a clinical science, with the latest standards of surgical placement, programming and medication management," he said. "We're bringing together the academic activities that will increase knowledge and understanding among treatment professionals while improving the quality of care for individual patients."


'/>"/>

Contact: Sandy Van
sandy@prpacific.com
808-526-1708
Cedars-Sinai Medical Center
Source:Eurekalert

Related medicine news :

1. Latest data from Cedars-Sinai vaccine study supports immune targeting of brain tumors
2. Cedars-Sinais mobile medical clinics receive $500,000 grant from California Community Foundation
3. Cedars-Sinai to hold first annual conference on stem cell therapies for neurological disorders
4. Cedars-Sinais mobile medical clinics receive grant from George Hoag Family Foundation
5. Cedars-Sinai research team awarded $1.9 million from CIRM to develop new tools and technologies
6. Cedars-Sinai Medical Genetics Institute director honored with lifetime achievement award
7. Cedars-Sinai nano-drug hits brain-tumor target found in 2001
8. Cedars-Sinai awarded $1.9 million from CIRM to develop stem cell treatments for osteoporosis
9. Cedars-Sinai Pathology and Laboratory Medicine chair recognized with 2 of the fields top honors
10. Adults demonstrate modified immune response after receiving massage, Cedars-Sinai researchers show
11. Bigge Building Cedars-Sinai New West Tower
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital ... area economy by obtaining investment capital for emerging technology companies. SCP has ... have already resulted in more than a million dollars of capital investment for ...
(Date:6/24/2016)... ... 24, 2016 , ... Venture Construction Group (VCG) sponsors Luke’s Wings ... 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. ... service members that have been wounded in battle and their families. Venture Construction Group ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... startling report released today, National Safety Council research shows ... plan to eliminate prescription opioid overdoses. Prescription Nation ... the worst drug crisis in recorded U.S. history, assigned a "Making ... , New Mexico , Tennessee ... states, three – Michigan , Missouri ...
(Date:6/23/2016)... WAYNE, Pa. , June 23, 2016 ... provider, will launch its next generation clinical outcomes platform, Bracket ... DIA Meeting held on June 26 – 30, 2016 in ... 6.0, the first electronic Clinical Outcome Assessment product of its ... DIA Booth #715. Bracket eCOA 6.0 is a ...
Breaking Medicine Technology: